Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,951 | 544 | 99.5% |
| Education | $49.20 | 7 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,068 | 81 | $0 (2024) |
| Lilly USA, LLC | $1,181 | 84 | $0 (2024) |
| Novo Nordisk Inc | $756.96 | 42 | $0 (2024) |
| Amgen Inc. | $604.91 | 38 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $536.32 | 33 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $434.20 | 20 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $329.36 | 25 | $0 (2023) |
| Merck Sharp & Dohme LLC | $275.30 | 19 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $264.56 | 14 | $0 (2022) |
| Eisai Inc. | $251.67 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,468 | 73 | Bayer Healthcare Pharmaceuticals Inc. ($237.14) |
| 2023 | $682.96 | 37 | Lilly USA, LLC ($184.79) |
| 2022 | $1,189 | 55 | AstraZeneca Pharmaceuticals LP ($271.42) |
| 2021 | $754.32 | 42 | Eisai Inc. ($105.21) |
| 2020 | $1,458 | 86 | AstraZeneca Pharmaceuticals LP ($363.68) |
| 2019 | $1,349 | 83 | Novo Nordisk Inc ($245.31) |
| 2018 | $1,425 | 88 | AstraZeneca Pharmaceuticals LP ($418.78) |
| 2017 | $1,675 | 87 | AstraZeneca Pharmaceuticals LP ($447.08) |
All Payment Transactions
551 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 10/08/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.64 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Orthofix Medical, Inc. | Cervical-Stim (Device) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Device | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Inflammation | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Respiratory | ||||||
| 08/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Biological | ||||||
| 08/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 128 | 220 | $34,436 | $18,923 |
| 2022 | 8 | 218 | 344 | $38,619 | $24,509 |
| 2021 | 11 | 263 | 489 | $55,957 | $36,536 |
| 2020 | 7 | 221 | 435 | $37,042 | $17,724 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 146 | $23,483 | $12,333 | 52.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 23 | $4,618 | $3,018 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 39 | $4,485 | $2,029 | 45.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $1,850 | $1,543 | 83.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 178 | $24,778 | $15,312 | 61.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 25 | $4,661 | $3,122 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 53 | $5,037 | $3,033 | 60.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $1,641 | $1,473 | 89.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 21 | 23 | $1,006 | $766.01 | 76.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $676.00 | $390.74 | 57.8% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 17 | 17 | $340.00 | $333.82 | 98.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 24 | $480.00 | $79.40 | 16.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 240 | $33,408 | $21,121 | 63.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 66 | $6,273 | $4,417 | 70.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 45 | $4,192 | $2,631 | 62.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 19 | $3,542 | $2,541 | 71.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $2,238 | $2,050 | 91.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $2,422 | $1,907 | 78.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 15 | $1,405 | $883.05 | 62.9% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 12 | 13 | $789.49 | $390.92 | 49.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 26 | $556.40 | $305.50 | 54.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $572.00 | $190.93 | 33.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 20 | 28 | $560.00 | $97.44 | 17.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 293 | $27,847 | $13,608 | 48.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 38 | $5,290 | $2,764 | 52.3% |
About Dr. Lena Bruce, M.D
Dr. Lena Bruce, M.D is a Family Medicine healthcare provider based in Santa Fe, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558322438.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lena Bruce, M.D has received a total of $10,000 in payments from pharmaceutical and medical device companies, with $1,468 received in 2024. These payments were reported across 551 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($9,951).
As a Medicare-enrolled provider, Bruce has provided services to 830 Medicare beneficiaries, totaling 1,488 services with total Medicare billing of $97,693. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Santa Fe, TX
- Active Since 03/30/2006
- Last Updated 01/06/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558322438
Products in Payments
- FARXIGA (Drug) $1,620
- TRULICITY (Drug) $472.76
- MOUNJARO (Drug) $447.90
- Kerendia (Drug) $434.20
- Ozempic (Drug) $326.48
- VYVANSE (Drug) $267.28
- TROKENDI XR (Drug) $266.47
- Aimovig (Biological) $256.61
- Otezla (Drug) $234.40
- JARDIANCE (Drug) $227.72
- CONTRAVE (Drug) $207.91
- Dayvigo (Drug) $179.19
- Tresiba (Drug) $168.90
- Azstarys (Drug) $168.30
- STIOLTO RESPIMAT (Drug) $151.52
- Adzenys XR-ODT (Drug) $143.35
- BELSOMRA (Drug) $138.61
- BYDUREON (Drug) $137.30
- BASAGLAR (Drug) $136.71
- NURTEC ODT (Drug) $134.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Fe
Dr. Wendy Johnson, Md, MD
Family Medicine — Payments: $53,424
Kurt Kastendieck, Md, MD
Family Medicine — Payments: $10,673
Debra Higginbotham, Md, MD
Family Medicine — Payments: $6,731
Luis Rigales, Md, MD
Family Medicine — Payments: $5,010
Dr. Gerzain Chavez, M.d, M.D
Family Medicine — Payments: $4,150
Aryan Caire, M.d, M.D
Family Medicine — Payments: $3,516